Neoadjuvant Multikinase Inhibitor in Patients With Locally Advanced Unresectable Thyroid Carcinoma

Background: Papillary thyroid carcinoma (PTC) is the most common and less aggressive thyroid cancer, but some patients may display locally advanced disease. Therapeutic options are limited in these cases, particularly for those patients with unresectable tumors. Neoadjuvant therapy is not part of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Nava, Carla Fernanda, Scheffel, Rafael Selbach, Cristo, Ana Patrícia, Ferreira, Carla Vaz, Weber, Shana, Zanella, André Borsatto, Paixão, Francisco Costa, Migliavaca, Alceu, Guimarães, José Ricardo, Graudenz, Marcia Silveira, Dora, José Miguel, Maia, Ana Luiza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817485/
https://www.ncbi.nlm.nih.gov/pubmed/31695679
http://dx.doi.org/10.3389/fendo.2019.00712

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6817485/
https://www.ncbi.nlm.nih.gov/pubmed/31695679
http://dx.doi.org/10.3389/fendo.2019.00712

Ejemplares similares